Curcumin and its allied analogues: epigenetic and health perspectives – a review M., Nadeem M., Khan M.A., Ahmed S., Imran A., Amir R.M., Arshad M.U., Rauf A., Saeed F., Khan S., Mehmood Z., Gilani S.A., Suleria H.A.R. (2017): Curcumin and its allied analogues: epigenetic and health perspectives – a review. Czech J. Food Sci., 35: 285-310.
download PDF
Curcumin (diferuoyl methane) is a yellow active ingredient present in turmeric. It is a homodimer of feruloylmethane that comprises a hydroxyl and methoxy group (heptadiene with two Michael acceptors), and α-, β-diketone. It contains various metabolites, i.e. hexahydrocurcumin (HHC), tetrahydrocurcumin (THC), octahydrocurcumin (OHC), dihydrocurcumin (DHC), curcumin sulphate, and curcumin glucuronide. Curcumin has been proven the most effective histone deacetylase (HDAC) inhibitor in HeLa nuclear extracts. It has the ability to affect the Akt, growth factors, NF-kB, and metastatic and angiogenic pathways. Curcumin has a strong therapeutic or preventive potential against several major human ailments, i.e. suppression of inflammation, cardiovascular, diabetes, tumorigenesis, chronic fatigue, antidepressant and neurological activities, depression, loss of muscle and bone, and neuropathic pain. In future, higher utilisation of curcumin as an active agent in food based products is required to curtail the human health disorders.
Abdou Asmaa Gaber, Hanout Hayam Mohamed (2008): Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study. Journal of Cutaneous Pathology, 35, 445-451
Aggarwal Bharat B., Sung Bokyung (2009): Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences, 30, 85-94
Aggarwal B.B., Kumar A., Bharti A.C. (2003): Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research. 23 (1A): 363–398.
Ammon Hermann, Wahl Martin (1991): Pharmacology of Curcuma longa. Planta Medica, 57, 1-7
Anand Preetha, Kunnumakkara Ajaikumar B., Newman Robert A., Aggarwal Bharat B. (2007): Bioavailability of Curcumin: Problems and Promises. Molecular Pharmaceutics, 4, 807-818
Araújo CAC, Leon LL (2001): Biological activities of Curcuma longa L.. Memórias do Instituto Oswaldo Cruz, 96, 723-728
Asai A., Miyazawa T. (2001): Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. The Journal of Nutrition, 131: 2932–2935.
Backs J. (2005): Control of Cardiac Growth by Histone Acetylation/Deacetylation. Circulation Research, 98, 15-24
Balasubramanyam Karanam, Varier Radhika A., Altaf Mohammed, Swaminathan Venkatesh, Siddappa Nagadenahalli B., Ranga Udaykumar, Kundu Tapas K. (2004): Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription. Journal of Biological Chemistry, 279, 51163-51171
BALOGUN Elisabeth, HOQUE Martha, GONG Pengfei, KILLEEN Erin, GREEN Colin J., FORESTI Roberta, ALAM Jawed, MOTTERLINI Roberto (2003): Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal, 371, 887-895
Bansal Shyam S., Kausar Hina, Aqil Farrukh, Jeyabalan Jeyaprakash, Vadhanam Manicka V., Gupta Ramesh C., Ravoori Srivani (2011): Curcumin implants for continuous systemic delivery: safety and biocompatibility. Drug Delivery and Translational Research, 1, 332-341
Baum Larry, Lam Christopher Wai Kei, Cheung Stanley Kwok-Kuen, Kwok Timothy, Lui Victor, Tsoh Joshua, Lam Linda, Leung Vivian, Hui Elsie, Ng Chelsia, Woo Jean, Chiu Helen Fung Kum, Goggins William B., Zee Benny Chung-Ying, Cheng King Fai, Fong Carmen Yuet Shim, Wong Adrian, Mok Hazel, Chow Moses Sing Sum, Ho Ping Chuen, Ip Siu Po, Ho Chung Shun, Yu Xiong Wen, Lai Caroline Yau Lin, Chan Ming-Houng, Szeto Samuel, Chan Iris Hiu Shuen, Mok Vincent (2008): Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease. Journal of Clinical Psychopharmacology, 28, 110-113
Beevers C.S., Huang S. (2011): Pharmacological and clinical properties of curcumin. Botanics: Targets and Therapy, 1: 5–18.
Bernabé-Pineda Marganta, Ramı́rez-Silva Maria Teresa, Romero-Romo Mario Alberto, González-Vergara Enrique, Rojas-Hernández Alberto (2004): Spectrophotometric and electrochemical determination of the formation constants of the complexes Curcumin–Fe(III)–water and Curcumin–Fe(II)–water. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 60, 1105-1113
Bharti A. C., Takada Y., Aggarwal B. B. (2004): Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF- B Ligand-Induced NF- B Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis. The Journal of Immunology, 172, 5940-5947
Bhaumik Sraboni, Jyothi M.Divya, Khar Ashok (2000): Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Letters, 483, 78-82
Bhawana , Basniwal Rupesh Kumar, Buttar Harpreet Singh, Jain V. K., Jain Nidhi (2011): Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study. Journal of Agricultural and Food Chemistry, 59, 2056-2061
Biswas S.K., McClure D., Jimenez L.A., Megson I.L., Rahman I. (2005): Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxidants & Redox Signaling, 7: 32–41.
Black Joshua C., Choi Janet E., Lombardo Sarah R., Carey Michael (2006): A Mechanism for Coordinating Chromatin Modification and Preinitiation Complex Assembly. Molecular Cell, 23, 809-818
Bloomgarden Z. T. (2007): Diabetes and Obesity: Part 1. Diabetes Care, 30, 3145-3151
Bondì M.L., Emma M.R., Botto C., Augello G., Azzolina A., DiGaudio F., Craparo E.F., Cavallaro G., Bachvarov D., Cervello M. (2017): Biocompatible lipid nanoparticles as carriers to improve curcumin efficacy in ovarian cancer treatment, Journal of Agricultural and Food Chemistry, 65: 1342–1352.
Bora-Tatar G., DayangaÇ-Erden, Demir A.S., Dalkara S., YelekÇ K., Erdem-Yurter H. (2009): Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies Bioorganic and Medicinal Chemistry, 17: 5219–5228.
Brooks Peter M. (2002): Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Current Opinion in Rheumatology, 14, 573-577
Brouet I., Ohshima H. (1995): Curcumin, an Anti-tumor Promoter and Anti-inflammatory Agent, Inhibits Induction of Nitric Oxide Synthase in Activated Macrophages. Biochemical and Biophysical Research Communications, 206, 533-540
Bruck Rafael, Ashkenazi Michal, Weiss Sigal, Goldiner Ilana, Shapiro Haim, Aeed Hussein, Genina Olga, Helpern Zamir, Pines Mark (2007): Prevention of liver cirrhosis in rats by curcumin. Liver International, 27, 373-383
Bush Jason A., Cheung K-John J., Li Gang (2001): Curcumin Induces Apoptosis in Human Melanoma Cells through a Fas Receptor/Caspase-8 Pathway Independent of p53. Experimental Cell Research, 271, 305-314
Cay M., Naziroğlu M., Simsek H., Aydilek N., Aksakal M., Demirci M. (2001): Effects of intraperitoneally administered vitamin C on antioxidative defense mechanism in rats with diabetes induced by streptozotocin. Research in Experimental Medicine, 200: 205–213.
Chan Marion Man-Ying, Huang Hsing-I, Fenton Marilyn Ruth, Fong Dunne (1998): In Vivo Inhibition of Nitric Oxide Synthase Gene Expression by Curcumin, a Cancer Preventive Natural Product with Anti-Inflammatory Properties. Biochemical Pharmacology, 55, 1955-1962
Chang Deh-Ming (2001): Curcumin: A heat shock response inducer and potential cytoprotector. Critical Care Medicine, 29, 2231-2232
Chang Ming-Tsung, Tsai Tong-Rong, Lee Chun-Yann, Wei Yu-Sheng, Chen Ying-Jie, Chen Chun-Ren, Tzen Jason T. C. (2013): Elevating Bioavailability of Curcumin via Encapsulation with a Novel Formulation of Artificial Oil Bodies. Journal of Agricultural and Food Chemistry, , 130926101811001-
Chattopadhyay I., Biswas K., Bandyopadhyay U., Banerjee R.K. (2004): Turmeric and curcumin: biological actions and medicinal applications. Current Science, 87: 44–53.
Chen Yan, Shu Wenxiu, Chen Weihua, Wu Qing, Liu Hongli, Cui Guohui (2007): Curcumin, both Histone Deacetylase and p300/CBP-Specific Inhibitor, Represses the Activity of Nuclear Factor Kappa B and Notch 1 in Raji Cells. Basic & Clinical Pharmacology & Toxicology, 101, 427-433
CHEN Y (2001): Alternative activation of extracellular signal-regulated protein kinases in curcumin and arsenite-induced HSP70 gene expression in human colorectal carcinoma cells. European Journal of Cell Biology, 80, 213-221
Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. (2001): Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research, 21: 2895–2900.
Cho J.W., Lee K.S., Kim C.W. (2007): Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. International Journal of Molecular Medicine; 19: 469–474.
Citron Martin (): Alzheimer's disease: treatments in discovery and development. Nature Neuroscience, 5, 1055-1057
Citron M. (2004): Strategies for disease modification in Alzheimer’s disease. Natural reviews. Neuroscience, 5: 677–685.
Cole G.M., Teter B., Frautschy S.A. (2007): Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology, 595: 197–212.
Dai Chongshan, Li Daowen, Gong Lijing, Xiao Xilong, Tang Shusheng (2016): Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial Pathway. Molecules, 21, 1061-
Dar Ahsana, Khatoon Shagufta (2000): Behavioral and Biochemical Studies of Dichloromethane Fraction From the Areca catechu Nut. Pharmacology Biochemistry and Behavior, 65, 1-6
Deeb D., Jiang H., Gao X., Hafner M.S., Wong H., Divine G., Chapman R.A., Dulchavsky S.A., Gautam S.C. (2004): Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of I kappa B alpha phosphorylation. Molecular Cancer Therapeutics, 3: 803–812.
Dekker Frank J., Ghizzoni Massimo, van der Meer Nanette, Wisastra Rosalina, Haisma Hidde J. (2009): Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorganic & Medicinal Chemistry, 17, 460-466
Duvoix Annelyse, Blasius Romain, Delhalle Sylvie, Schnekenburger Michaël, Morceau Franck, Henry Estelle, Dicato Mario, Diederich Marc (2005): Chemopreventive and therapeutic effects of curcumin. Cancer Letters, 223, 181-190
Ehrlich Melanie (2009): DNA hypomethylation in cancer cells. Epigenomics, 1, 239-259
Elsharkawy A. M., Oakley F., Mann D. A. (2005): The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis, 10, 927-939
Farhangkhoee H., Khan Z.A., Chen S., Chakrabarti S. (2006): Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutrition and Metabolism, 18, 3: 27. doi: 10.1186/1743-7075-3-27
Ferreira Nelson, Santos Sónia A.O., Domingues Maria Rosário M., Saraiva Maria João, Almeida Maria Rosário (2013): Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832, 39-45
Fujiwara Hideya, Hosokawa Masaya, Zhou Xiaorong, Fujimoto Shimpei, Fukuda Kazuhito, Toyoda Kentaro, Nishi Yuichi, Fujita Yoshihito, Yamada Kotaro, Yamada Yuichiro, Seino Yutaka, Inagaki Nobuya (2008): Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Research and Clinical Practice, 80, 185-191
Garcea G, Jones D J L, Singh R, Dennison A R, Farmer P B, Sharma R A, Steward W P, Gescher A J, Berry D P (2004): Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer, 90, 1011-1015
García-Niño Wylly Ramsés, Pedraza-Chaverrí José (2014): Protective effect of curcumin against heavy metals-induced liver damage. Food and Chemical Toxicology, 69, 182-201
Gardner D.G. (2003): Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends in Endocrinology and Metabolism, 14: 411–416.
Goel Ajay, Boland C.Richard, Chauhan Dharam P (2001): Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Letters, 172, 111-118
Gonzales Amanda M, Orlando Robert A (2008): Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutrition & Metabolism, 5, 17-
Gopinath D, Ahmed M.Rafiuddin, Gomathi K, Chitra K, Sehgal P.K, Jayakumar R (2004): Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials, 25, 1911-1917
Gupta Suresh Kumar, Kumar Binit, Nag Tapas Chandra, Agrawal Shyam Sunder, Agrawal Renu, Agrawal Puneet, Saxena Rohit, Srivastava Sushma (2011): Curcumin Prevents Experimental Diabetic Retinopathy in Rats Through Its Hypoglycemic, Antioxidant, and Anti-Inflammatory Mechanisms. Journal of Ocular Pharmacology and Therapeutics, 27, 123-130
Hahm Eun-Ryeong, Gho Yong Song, Park Seyeon, Park Chihoon, Kim Kyu-Won, Yang Chul-Hak (2004): Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochemical and Biophysical Research Communications, 321, 337-344
Halliwell B., Gutteridge J.M.C. (2002): Free Radicals in Biology and Medicine. 3rd Ed. New York, Oxford University Press Inc.: 105–245.
Han Ying-Rui, Zhu Jin-Jin, Wang Yu-Rong, Wang Xing-Sheng, Liao Yong-Hong (2011): A simple RP-HPLC method for the simultaneous determination of curcumin and its prodrug, curcumin didecanoate, in rat plasma and the application to pharmacokinetic study. Biomedical Chromatography, 25, 1144-1149
Heng M.C.Y., Song M.K., Harker J., Heng M.K. (2000): Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. British Journal of Dermatology, 143, 937-949
Hong J. (2004): Modulation of arachidonic acid metabolism by curcumin and related  -diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25, 1671-1679
Hsu C.H., Cheng A.L. (2007): Clinical studies with curcumin. Advances in Experimental Medicine and Biology, 595: 471–480.
Hunt Joan S, Petroff Margaret G, Morales Pedro, Sedlmayr Peter, Geraghty Daniel E, Ober Carole (2000): HLA-G in reproduction: studies on the maternal–fetal interface. Human Immunology, 61, 1113-1117
Hussan Farida, Ibraheem Nawwar Ghassan, Kamarudin Taty Anna, Shuid Ahmad Nazrun, Soelaiman Ima Nirwana, Othman Faizah (2012): Curcumin Protects against Ovariectomy-Induced Bone Changes in Rat Model. Evidence-Based Complementary and Alternative Medicine, 2012, 1-7
Illek B., Lizarzaburu M.E., Lee V., Nantz M.H., Kurth M.J., Fischer H. (2000): Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin. American Journal of Physiology-Cell Physiology, 279: C1838–C1844.
Iqbal Mohammad, Okazaki Yasumasa, Okada Shigeru (2003): In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratogenesis, Carcinogenesis, and Mutagenesis, 23, 151-160
Ireson C., Orr S., Jones D.J., Verschoyle R., Lim C.K., Luo J.L., Howells L., Plummer S., Jukes R., Williams M., Steward W.P., Gescher A. (2001): Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research, 61: 1058–1064.
Ireson C.R., Jones D.J., Orr S., Coughtrie M.W., Boocock D.J., Williams M.L., Farmer P.B., Steward W.P., Gescher A.J. (2002): Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology, Biomarkers and Prevention, 11: 105–111.
Jagetia Ganesh Chandra, Rajanikant Golgod Krishnamurthy (2005): Curcumin Treatment Enhances the Repair and Regeneration of Wounds in Mice Exposed to Hemibody ??-Irradiation. Plastic and Reconstructive Surgery, 115, 515-528
Jana Nihar Ranjan, Dikshit Priyanka, Goswami Anand, Nukina Nobuyuki (2004): Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway. Journal of Biological Chemistry, 279, 11680-11685
Jaruga E., Salvioli S., Dobrucki J., Chrul S., Bandorowicz-Pikuła J., Sikora E., Franceschi C., Cossarizza A., Bartosz G. (1998a): Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Letters, 433: 287–293.
Jaruga E., Sokal A., Chrul S., Bartosz G. (1998b): Apoptosis-independent alterations in membrane dynamics induced by curcumin. Experimental Cell Research, 245: 303–312.
JOE B., VIJAYKUMAR M., LOKESH B. R. (2004): Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action. Critical Reviews in Food Science and Nutrition, 44, 97-111
Kalpana C., Menon V.P. (2004): Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Italian Journal of Biochemistry, 53: 82–86.
Kam Antony, Li Kong M, Razmovski-Naumovski Valentina, Nammi Srinivas, Chan Kelvin, Grau Georges E, Li George Q (2015): Curcumin Reduces Tumour Necrosis Factor-Enhanced Annexin V-Positive Microparticle Release in Human Vascular Endothelial Cells. Journal of Pharmacy & Pharmaceutical Sciences, 18, 424-
Kang Soo-Kyung, Cha Seung-Heun, Jeon Hyo-Gon (2006): Curcumin-induced Histone Hypoacetylation Enhances Caspase-3-dependent Glioma Cell Death and Neurogenesis of Neural Progenitor Cells. Stem Cells and Development, 15, 165-174
Karunagaran D., Rashmi R., Kumar T. (2005): Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy. Current Cancer Drug Targets, 5, 117-129
Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., Reddy B.S. (1999): Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Research, 59: 597–601.
KHOPDE Sujata M., PRIYADARSINI K. Indira, GUHA Shambhu Nath, SATAV Jagganath G., VENKATESAN Parameswaran, RAO Mysore N. Aswathanarana (2014): Inhibition of Radiation-Induced Lipid Peroxidation by Tetrahydrocurcumin: Possible Mechanisms by Pulse Radiolysis. Bioscience, Biotechnology, and Biochemistry, 64, 503-509
Kim H. Y., Park E. J., Joe E.-h., Jou I. (2003): Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia. The Journal of Immunology, 171, 6072-6079
Kim J.-H., Xu C., Keum Y.-S., Reddy B., Conney A., Kong A.-N. T. (2006): Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with  -phenylethyl isothiocyanate and curcumin. Carcinogenesis, 27, 475-482
Kim Teayoun, Davis Jessica, Zhang Albert J., He Xiaoming, Mathews Suresh T. (2009): Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochemical and Biophysical Research Communications, 388, 377-382
Kim D. W. (): Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis, 21, 871-879
Kowluru Renu A, Kanwar Mamta (): Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition & Metabolism, 4, 8-
Kukongviriyapan Upa, Apaijit Kwanjit, Kukongviriyapan Veerapol (2016): Oxidative Stress and Cardiovascular Dysfunction Associated with Cadmium Exposure: Beneficial Effects of Curcumin and Tetrahydrocurcumin. The Tohoku Journal of Experimental Medicine, 239, 25-38
Kulkarni Shrinivas K., Bhutani Mohit Kumar, Bishnoi Mahendra (2008): Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology, 201, 435-442
Kumar A., Kingdon E., Norman J. (2005): The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. FASEB Journal, 9: 443–445.
Kurd Shanu Kohli, Smith Nana, VanVoorhees Abby, Troxel Andrea B., Badmaev Vladimir, Seykora John T., Gelfand Joel M. (2008): Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. Journal of the American Academy of Dermatology, 58, 625-631
Kurien Biji T., Singh Anil, Matsumoto Hiroyuki, Scofield R. Hal (2007): Improving the Solubility and Pharmacological Efficacy of Curcumin by Heat Treatment. ASSAY and Drug Development Technologies, 5, 567-576
Lee H.S. (2006): Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresource Technology, 97, 1372-1376
Lee Jie-Jen, Huang Wu-Tein, Shao Dong-Zi, Liao Jyh-Fei, Lin Mao-Tsun (2003): Blocking NF-κB Activation May Be an Effective Strategy in the Fever Therapy. The Japanese Journal of Physiology, 53, 367-375
Lee Chong-Ki, Ki Sung-Hwan, Choi Jun-Shik (2011): Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharmaceutics & Drug Disposition, 32, 245-251
Lee Ka-Heng, Chow Yuh-Lit, Sharmili Vidyadaran, Abas Faridah, Alitheen Noorjahan Banu Mohamed, Shaari Khozirah, Israf Daud Ahmad, Lajis Nordin Haji, Syahida Ahmad (2012): BDMC33, A Curcumin Derivative Suppresses Inflammatory Responses in Macrophage-Like Cellular System: Role of Inhibition in NF-κB and MAPK Signaling Pathways. International Journal of Molecular Sciences, 13, 2985-3008
Lelli Diana, Pedone Claudio, Sahebkar Amirhosssein (2017): Curcumin and treatment of melanoma: The potential role of microRNAs. Biomedicine & Pharmacotherapy, 88, 832-834
Liao S., Lin Jerry, Dang M. T., Zhang Hanzhong, Kao Y.-H., Fukuchi Junichi, Hiipakka Richard A. (2001): Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Archives of Dermatological Research, 293, 200-205
Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. (2001): The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience, 21: 8370–8377.
Literat A., Su F., Norwicki M., Durand M., Ramanathan R., Jones C.A., Minoo P., Kwong K.Y. (2001): Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sciences, 70, 253-267
Liu Chi-Hsien, Chang Fu-Yen (2011): Development and Characterization of Eucalyptol Microemulsions for Topic Delivery of Curcumin. CHEMICAL & PHARMACEUTICAL BULLETIN, 59, 172-178
Liu Z.J., Han G., Yu J.G., Dai H.G. (2009): Preparation and drug releasing property of curcumin nanoparticles. Zhong Yao Cai, 32: 277–279.
Liu H., Moroi Y., Yasumoto S., Kokuba H., Imafuku S., Nakahara T., Dainichi T., Uchi H., Tu Y., Furue M., Urabe K. (2006): Immunohistochemical localization of activated Stat3 and hTERT protein in psoriasis vulgaris. European Journal of Dermatology, 16: 205–207.
Liu Rui, Liu Zhidong, Zhang Chengui, Zhang Boli (2011): Gelucire44/14 as a novel absorption enhancer for drugs with different hydrophilicities: In vitro and in vivo improvement on transcorneal permeation. Journal of Pharmaceutical Sciences, 100, 3186-3195
Lodha R., Bagga A. (2000): Traditional Indian systems of medicine. Annals, Academy of Medicine, Singapore, 29: 37–41.
Lohse M.J., Engelhardt S., Eschenhagen T. (2003a): What is the role of beta-adrenergic signaling in heart failure? Circulation Research, 93: 896–906.
Lohse M.J., Vilardaga J.P., Bunemann M. (2003b): Direct optical recording of intrinsic efficacy at a G protein-coupled receptor. Life Sciences, 74: 397–404.
Mani Haresh, Sidhu Gurmel S., Kumari Ranjana, Gaddipati Jaya P., Seth Pankaj, Maheshwari Radha K. (2002): Curcumin differentially regulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing. BioFactors, 16, 29-43
Manikandan Panchatcharam, Sumitra Miriyala, Aishwarya Srinivasan, Manohar Bhakthavatsalam Murali, Lokanadam Beema, Puvanakrishnan Rengarajulu (2004): Curcumin modulates free radical quenching in myocardial ischaemia in rats. The International Journal of Biochemistry & Cell Biology, 36, 1967-1980
Neckers Len, Trepel Jane, Lee Sunmin, Chung Eun-Joo, Lee Min-Jung, Jung Yun-Jin, Marcu Monica (2006): Curcumin is an Inhibitor of p300 Histone Acetylatransferase. Medicinal Chemistry, 2, 169-174
Marwick John A, Ito Kazuhiro, Adcock Ian M, Kirkham Paul A (2007): Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Expert Opinion on Therapeutic Targets, 11, 745-755
Mayanglambam Azad, Dangelmaier Carol A., Thomas Dafydd, Damodar Reddy C., Daniel James L., Kunapuli Satya P. (2010): Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCγ2. Platelets, 21, 211-220
Meja Koremu K., Rajendrasozhan Saravanan, Adenuga David, Biswas Saibal K., Sundar Isaac K., Spooner Gillian, Marwick John A., Chakravarty Probir, Fletcher Danielle, Whittaker Paul, Megson Ian L., Kirkham Paul A., Rahman Irfan (2008): Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2. American Journal of Respiratory Cell and Molecular Biology, 39, 312-323
Miyamoto S. (2006): Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo. Circulation, 113, 679-690
Morimoto Tatsuya, Sunagawa Yoichi, Kawamura Teruhisa, Takaya Tomohide, Wada Hiromichi, Nagasawa Atsushi, Komeda Masashi, Fujita Masatoshi, Shimatsu Akira, Kita Toru, Hasegawa Koji (): The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. Journal of Clinical Investigation, , -
Motterlini Roberto, Foresti Roberta, Bassi Rekha, Green Colin J (2000): Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biology and Medicine, 28, 1303-1312
Motterlini Roberto, Green Colin J., Foresti Roberta (2002): Regulation of Heme Oxygenase-1 by Redox Signals Involving Nitric Oxide. Antioxidants & Redox Signaling, 4, 615-624
Mukhopadhyay Asok, Bueso-Ramos Carlos, Chatterjee Devasis, Pantazis Panayotis, Aggarwal Bharat B (2001): Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene, 20, 7597-7609
Naito Michitaka, Wu Xiaohong, Nomura Hideki, Kodama Michiteru, Kato Yuriko, Kato Yoji, Osawa Toshihiko (2002): The Protective Effects of Tetrahydrocurcumin on Oxidative Stress in Cholesterol-fed Rabbits. Journal of Atherosclerosis and Thrombosis, 9, 243-250
Narayan Satya (2003): Curcumin, A Multi-Functional Chemopreventive Agent, Blocks Growth of Colon Cancer Cells by Targeting β-Catenin-Mediated Transactivation and Cell–Cell Adhesion Pathways. Journal of Molecular Histology, 35, 301-307
Nariya Ankit, Pathan Ambar, Shah Naumita, Chettiar Shiva, Patel Alpesh, Dattani Jignasha, Chandel Divya, Rao Mandava, Jhala Devendrasinh (2017): Ameliorative effects of curcumin against lead induced toxicity in human peripheral blood lymphocytes culture. Drug and Chemical Toxicology, , 1-8
Neuman M.G. (2003): Cytokines – central factors in alcoholic liver disease. Alcohol Research and Health, 27: 307–216.
Oakley Fiona, Mann Jelena, Nailard Sarah, Smart David E., Mungalsingh Narendra, Constandinou Christothea, Ali Shakir, Wilson Susan J., Millward-Sadler Harry, Iredale John P., Mann Derek A. (2005): Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury. The American Journal of Pathology, 166, 695-708
Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., Osawa T. (2011): Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. Journal of Nutrition, 131: 2090–2095.
Olszanecki R., Jawień J., Gajda M., Mateuszuk L., Gebska A., Korabiowska M., Chłopicki S., Korbut R. (2005): Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. Journal of Physiology and Pharmacology, 56: 627–635.
Ono Kenjiro, Hasegawa Kazuhiro, Naiki Hironobu, Yamada Masahito (2004): Curcumin has potent anti-amyloidogenic effects for Alzheimer's ?-amyloid fibrils in vitro. Journal of Neuroscience Research, 75, 742-750
Ozaki Ken, Kawata Yasuhiro, Amano Shigeru, Hanazawa Shigemasa (2000): Stimulatory effect of curcumin on osteoclast apoptosis. Biochemical Pharmacology, 59, 1577-1581
Padmaja S., Raju T.N. (2004): Antioxidant effect of curcumin in selenium induced cataract of Wistar rats. Indian Journal of Experimental Biology, 42: 601–603.
Pan Min-Hsiung, Lin-Shiau Shoei-Yn, Lin Jen-Kun (2000): Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages. Biochemical Pharmacology, 60, 1665-1676
Pandelidou Maria, Dimas Konstantinos, Georgopoulos Aristidis, Hatziantoniou Sophia, Demetzos Costas (2011): Preparation and Characterization of Lyophilised EGG PC Liposomes Incorporating Curcumin and Evaluation of Its Activity Against Colorectal Cancer Cell Lines. Journal of Nanoscience and Nanotechnology, 11, 1259-1266
Pandya Utpal, Saini Manjit K., Jin Gui F., Awasthi Sanjay, Godley Bernard F., Awasthi Yogesh C. (2000): Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicology Letters, 115, 195-204
Pari L (2004): Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacological Research, 49, 481-486
Pari L., Amali D.R. (2005): Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. Journal of Pharmacology and Pharmaceutical Sciences, 8: 115–123.
Pari Leelavinothan, Murugan Pidaran (2005): EFFECT OF TETRAHYDROCURCUMIN ON BLOOD GLUCOSE, PLASMA INSULIN AND HEPATIC KEY ENZYMES IN STREPTOZOTOCIN INDUCED DIABETIC RATS. Journal of Basic and Clinical Physiology and Pharmacology, 16, -
Pari Leelavinothan, Murugan Pidaran (2006): Tetrahydrocurcumin: Effect on Chloroquine-Mediated Oxidative Damage in Rat Kidney. Basic <html_ent glyph="@amp;" ascii="&amp;"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&amp;"/> Toxicology, 99, 329-334
PARK EUN-JEON, JEON CHUL HYUN, KO GEONIL, KIM JAEBAEK, SOHN DONG HWAN (2000): Protective Effect of Curcumin in Rat Liver Injury Induced by Carbon Tetrachloride. Journal of Pharmacy and Pharmacology, 52, 437-440
Payton Florastina, Sandusky Peter, Alworth William L. (2007): NMR Study of the Solution Structure of Curcumin. Journal of Natural Products, 70, 143-146
Peschel Dieter, Koerting Ramona, Nass Norbert (2007): Curcumin induces changes in expression of genes involved in cholesterol homeostasis. The Journal of Nutritional Biochemistry, 18, 113-119
Pfeiffer Erika, Hoehle Simone I., Walch Stephan G., Riess Alexander, Sólyom Anikó M., Metzler Manfred (2007): Curcuminoids Form Reactive Glucuronides In Vitro. Journal of Agricultural and Food Chemistry, 55, 538-544
Phan Toan-Thang, See Patrick, Lee Seng-Teik, Chan Sui-Yung (2001): Protective Effects of Curcumin against Oxidative Damage on Skin Cells In Vitro: Its Implication for Wound Healing. The Journal of Trauma: Injury, Infection, and Critical Care, 51, 927-931
Premanand Chinnaraj, Rema Mohan, Sameer Mahmood Z., Sujatha Mohan, Balasubramanyam Muthusamy (2006): Effect of Curcumin on Proliferation of Human Retinal Endothelial Cells under In Vitro Conditions. Investigative Opthalmology & Visual Science, 47, 2179-
PRICE LISA C., BUESCHER R.W. (1997): Kinetics of Alkaline Degradation of the Food Pigments Curcumin and Curcuminoids. Journal of Food Science, 62, 267-269
Quaglino D., Nanney L.B., Kennedy R., Davidson J.M. (1990): Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. Laboratory Investigation, 63: 307–319.
Raisz L. G. (2005): Pathogenesis of osteoporosis: concepts, conflicts, and prospects. Journal of Clinical Investigation, 115, 3318-3325
Ram Arjun, Das Moumita, Ghosh Balaram (2003): Curcumin Attenuates Allergen-Induced Airway Hyperresponsiveness in Sensitized Guinea Pigs. Biological & Pharmaceutical Bulletin, 26, 1021-1024
Ramadori Giuliano, Armbrust Thomas (2001): Cytokines in the liver. European Journal of Gastroenterology & Hepatology, 13, 777-784
Ravindran J., Prasad S., Aggarwal B.B. (2009): Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS Journal, 11: 495–510.
Ray Aramita, Rana Santanu, Banerjee Durba, Mitra Arkadeep, Datta Ritwik, Naskar Shaon, Sarkar Sagartirtha (2016): Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicology and Applied Pharmacology, 290, 54-65
Reddy P Hemachandra, Manczak Maria, Yin Xiangling, Grady Mary Catharine, Mitchell Andrew, Kandimalla Ramesh, Kuruva Chandra Sekhar (2016): Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease. Journal of Investigative Medicine, 64, 1220-1234
Renard P., Delaive E., Van Steenbrugge M., Remacle J., Raes M. (2001): Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation? Antioxidants and Redox Signaling, 3: 329–340.
Rithaporn Tara, Monga Manoj, Rajasekaran Mahadevan (2003): Curcumin: a potential vaginal contraceptive. Contraception, 68, 219-223
Sameermahmood Zaheer, Balasubramanyam Muthuswamy, Saravanan Thangavel, Rema Mohan (2008): Curcumin Modulates SDF-1α/CXCR4–Induced Migration of Human Retinal Endothelial Cells (HRECs). Investigative Opthalmology & Visual Science, 49, 3305-
Sandur Santosh K., Pandey Manoj K., Sung Bokyung, Ahn Kwang Seok, Murakami Akira, Sethi Gautam, Limtrakul Pornngarm, Badmaev Vladimir, Aggarwal Bharat B. (2007): Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 28, 1765-1773
Sano Masanori, Minamino Tohru, Toko Haruhiro, Miyauchi Hideyuki, Orimo Masayuki, Qin Yingjie, Akazawa Hiroshi, Tateno Kaoru, Kayama Yosuke, Harada Mutsuo, Shimizu Ippei, Asahara Takayuki, Hamada Hirofumi, Tomita Shuhei, Molkentin Jeffrey D., Zou Yunzeng, Komuro Issei (2007): p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature, 446, 444-448
Scapagnini G. (): Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers. Molecular Pharmacology, 61, 554-561
Shao Junfei, Zheng Donghui, Jiang Zhifeng, Xu Huae, Hu Yong, Li Xiaolin, Lu Xiaowei (2011): Curcumin delivery by methoxy polyethylene glycol–poly(caprolactone)  nanoparticles inhibits the growth of C6 glioma cells. Acta Biochimica et Biophysica Sinica, 43, 267-274
SHAPIRO HAIM, ASHKENAZI MICHAL, WEIZMAN NIR, SHAHMUROV MARK, AEED HUSSEIN, BRUCK RAFAEL (2006): Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. Journal of Gastroenterology and Hepatology, 21, 358-366
Sharma R. A. (2004): Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance. Clinical Cancer Research, 10, 6847-6854
Sharma R.A., Steward W.P., Gescher A.J. (2007): Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology, 595: 453–470.
Sharma Sameer, Chopra Kanwaljit, Kulkarni Shrinivas K. (2007): Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytotherapy Research, 21, 278-283
SHISHODIA S. (2005): Curcumin: Getting Back to the Roots. Annals of the New York Academy of Sciences, 1056, 206-217
Shoba Guido, Joy David, Joseph Thangam, Majeed M., Rajendran R., Srinivas P. (1998): Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers. Planta Medica, 64, 353-356
Simpson Stephen J., Holländer Georg A., Mizoguchi Emiko, Allen Deborah, Bhan Atul K., Wang Baoping, Terhorst Cox (1997): Expression of pro-inflammatory cytokines by TCRαβ+ T and TCRγδ+ T cells in an experimental model of colitis. European Journal of Immunology, 27, 17-25
Singh Sanjaya, Aggarwal Bharat B. (1995): Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane). Journal of Biological Chemistry, 270, 24995-25000
Singh M, Sasi P, Gupta V H, Rai G, Amarapurkar D N, Wangikar P P (2012): Protective effect of curcumin, silymarin and N -acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model. Human & Experimental Toxicology, 31, 788-797
Balapure AnilK, Dixit Jaya, Lodha Divya, Ranjan Vishal, Sharma Ramesh, Shyam Hari, Singh Neetu, Singh Aparna, Verma Umesh, Zaidi Deeba (2012): Insulin catalyzes the curcumin-induced wound healing: An in vitro model for gingival repair. Indian Journal of Pharmacology, 44, 458-
Srivastava K.C., Bordia A., Verma S.K. (1995): Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins, Leukotrienes and Essential Fatty Acids, 52, 223-227
Strimpakos Alexios S., Sharma Ricky A. (2008): Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials. Antioxidants & Redox Signaling, 10, 511-546
Suda Tatsuo, Takahashi Naoyuki, Udagawa Nobuyuki, Jimi Eijiro, Gillespie Matthew T., Martin T. John (1999): Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families. Endocrine Reviews, 20, 345-357
Sugiyama Yosunori, Kawakishi Shunro, Osawa Toshihiko (1996): Involvement of the β-diketone moiety in the antioxidative Mechanism of Tetrahydrocurcumin. Biochemical Pharmacology, 52, 519-525
Sun Jiabei, Bi Chao, Chan Hok Man, Sun Shaoping, Zhang Qingwen, Zheng Ying (2013): Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids and Surfaces B: Biointerfaces, 111, 367-375
Surh Young-Joon (2003): Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3, 768-780
Surh Young-Joon, Chun Kyung-Soo, Cha Hyun-Ho, Han Seong Su, Keum Young-Sam, Park Kwang-Kyun, Lee Sang Sup (2001): Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 480-481, 243-268
Thaloor D., Miller K.J., Gephart J., Mitchell P.O., Pavlath G.K. (1999): Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. American Journal of Physiology, 277: C320–C329.
Thapa Arjun, Jett Stephen D., Chi Eva Y. (2016): Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway. ACS Chemical Neuroscience, 7, 56-68
Thiyagarajan Meenakshisundaram, Sharma Shyam S (2004): Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences, 74, 969-985
Thompson Katherine H., Böhmerle Karin, Polishchuk Elena, Martins Candice, Toleikis Philip, Tse Jeremy, Yuen Violet, McNeill John H., Orvig Chris (2004): Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. Journal of Inorganic Biochemistry, 98, 2063-2070
Tomita Mariko, Matsuda Takehiro, Kawakami Hirochika, Uchihara Jun-nosuke, Okudaira Taeko, Masuda Masato, Ohshiro Kazuiku, Mori Naoki (2006): THIS ARTICLE HAS BEEN RETRACTED Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines. Cancer Science, 97, 322-327
Tønnesen Hanne Hjorth, de Vries Henk, Karlsen Jan, Van Henegouwen Gerard Beijersbergen (1987): Studies on Curcumin and Curcuminoids IX: Investigation of the Photobiological Activity of Curcumin Using Bacterial Indicator Systems. Journal of Pharmaceutical Sciences, 76, 371-373
Tourkina Elena, Gooz Pal, Oates James C., Ludwicka-Bradley Anna, Silver Richard M., Hoffman Stanley (2004): Curcumin-Induced Apoptosis in Scleroderma Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 31, 28-35
Vajragupta Opa, Boonchoong Preecha, Morris Garrett M., Olson Arthur J. (2005): Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorganic & Medicinal Chemistry Letters, 15, 3364-3368
Vamvouris Theodora, Hadi Suhail (2006): A Review of the Treatment of Psoriasis with Infliximab. Reviews on Recent Clinical Trials, 1, 201-205
Van Erk M.J., Teuling E., Staal Y.C., Huybers S., Van Bladeren P.J., Aarts J.M., Van Ommen B. (2004): Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. Journal of Carcinogenesis, 3: 8. doi: 10.1186/1477-3163-3-8
Vareed S. K., Kakarala M., Ruffin M. T., Crowell J. A., Normolle D. P., Djuric Z., Brenner D. E. (2008): Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects. Cancer Epidemiology Biomarkers & Prevention, 17, 1411-1417
Veldman Emma R., Jia Zhisheng, Halldin Christer, Svedberg Marie M. (2016): Amyloid binding properties of curcumin analogues in Alzheimer’s disease postmortem brain tissue. Neuroscience Letters, 630, 183-188
Wang Ying-Jan, Pan Min-Hsiung, Cheng Ann-Lii, Lin Liang-In, Ho Yuan-Soon, Hsieh Chang-Yao, Lin Jen-Kun (1997): Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis, 15, 1867-1876
Wang D., Veena M.S., Stevenson K., Tang C., Ho B., Suh J.D., Duarte V.M., Faull K.F., Mehta K., Srivatsan E.S., Wang M.B. (2008a): Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway. Clinical Cancer Research, 14: 6228–6236.
Wang R., Li Y.B., Li Y.H., Xu Y., Wu H.L., Li X.J. (2008b): Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Research, 1210: 84–91.
Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B., Li X.J. (2008c): The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European Journal of Pharmacology, 578: 43–50.
Wang Nan, Wang Feng, Gao Youshui, Yin Peipei, Pan Chenhao, Liu Wei, Zhou Zubin, Wang Jiaxiang (2016): Curcumin protects human adipose-derived mesenchymal stem cells against oxidative stress-induced inhibition of osteogenesis. Journal of Pharmacological Sciences, 132, 192-200
Weber Karl T. (2003): A Neuroendocrine-Immune Interface. Herz, 28, 692-701
Weber Waylon M., Hunsaker Lucy A., Gonzales Amanda M., Heynekamp Justin J., Orlando Robert A., Deck Lorraine M., Vander Jagt David L. (2006): TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochemical Pharmacology, 72, 928-940
Wongcharoen Wanwarang, Phrommintikul Arintaya (2009): The protective role of curcumin in cardiovascular diseases. International Journal of Cardiology, 133, 145-151
Wu L.X., Xu J.H., Wu G.H., Chen Y.Z. (2003a): Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway. Acta Pharmacologica Sinica, 24: 1155–1160.
Xu J., Fu Y., Chen A. (2003b): Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. American Journal of Physiology-Gastrointestinal and Liver Physiology, 285: 20–30.
Xu M., Deng B., Chow Y.L., Zhao Z.Z., Hu B. (2007a): Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. Journal of Ethnopharmacology, 112: 292–299.
Xu W.S., Parmigiani R.B., Marks P.A. (2007b): Histone deacetylase inhibitors: molecular mechanisms of action. Oncogenesis, 26: 5541–5552.
Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. (2005a): The effects of curcumin on depressive-like behaviors in mice. European Journal of Pharmacology, 518: 40–46.
Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. (2005b): Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology Biochemistry Behavior, 2: 200–206.
Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., Li X. (2006): Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Research, 112: 56–64.
Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., Ogle W.O. (2007): Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research, 116: 9–18.
Yang Fusheng, Lim Giselle P., Begum Aynun N., Ubeda Oliver J., Simmons Mychica R., Ambegaokar Surendra S., Chen Pingping P., Kayed Rakez, Glabe Charles G., Frautschy Sally A., Cole Gregory M. (2005): Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo. Journal of Biological Chemistry, 280, 5892-5901
Yang Kuo-Yi, Lin Lei-Chwen, Tseng Ting-Yu, Wang Shau-Chun, Tsai Tung-Hu (2007): Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. Journal of Chromatography B, 853, 183-189
Yang Mao-Wei, Wang Tong-Hao, Yan Pei-Pei, Chu Li-Wei, Yu Jiang, Gao Zhi-Da, Li Yuan-Zhou, Guo Bao-Lei (2011): Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine, 18, 205-213
Yang Jingzhe, Wang Chengli, Zhang Zhijie, Chen Xiaojun, Jia Yusen, Wang Bin, Kong Tao (2017): Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway. APMIS, 125, 134-140
Yeon K.Y., Kim S.A., Kim Y.H., Lee M.K., Ahn D.K., Kim H.J., Kim J.S., Jung S.J., Oh S.B. (2009): Curcumin Produces an Antihyperalgesic Effect via Antagonism of TRPV1. Journal of Dental Research, 89, 170-174
Zeitlin P. (2004): Can curcumin cure cystic fibrosis? New England Journal Medicine, 351: 606–608.
Zhang L., Diao R. Y., Duan Y. G., Yi T. H., Cai Z. M. (2017): In vitro antioxidant effect of curcumin on human sperm quality in leucocytospermia. Andrologia, , e12760-
Zhang Yu, Xue Ying-bo, Li Hang, Qiu Dong, Wang Zhi-wei, Tan Shi-sheng (2017): Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells. Nutrients, 9, 109-
Zheng Shizhong, Yumei Fu, Chen Anping (2007): De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radical Biology and Medicine, 43, 444-453
Zheng Ruzhen, Deng Qinghua, Liu Yuehua, Zhao Pengjun (2017): Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway. Medical Science Monitor, 23, 163-171
download PDF

© 2021 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti